Evogene Ltd (EVGN)
0.6589
+0.01
(+1.34%)
USD |
NASDAQ |
May 17, 16:00
0.6589
0.00 (0.00%)
After-Hours: 20:00
Evogene Net Income (Quarterly): -6.601M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.601M |
| September 30, 2023 | -3.984M |
| June 30, 2023 | -7.023M |
| March 31, 2023 | -6.271M |
| December 31, 2022 | -2.998M |
| September 30, 2022 | -6.544M |
| June 30, 2022 | -8.821M |
| March 31, 2022 | -8.275M |
| December 31, 2021 | -7.371M |
| September 30, 2021 | -7.61M |
| June 30, 2021 | -6.21M |
| March 31, 2021 | -6.602M |
| December 31, 2020 | -8.122M |
| September 30, 2020 | -4.786M |
| June 30, 2020 | -4.238M |
| March 31, 2020 | -6.228M |
| December 31, 2019 | -6.078M |
| September 30, 2019 | -4.231M |
| June 30, 2019 | -4.094M |
| March 31, 2019 | -3.709M |
| December 31, 2018 | -5.801M |
| September 30, 2018 | -4.802M |
| June 30, 2018 | -4.769M |
| March 31, 2018 | -5.386M |
| Date | Value |
|---|---|
| December 31, 2017 | -6.224M |
| September 30, 2017 | -5.024M |
| June 30, 2017 | -4.743M |
| March 31, 2017 | -4.847M |
| December 31, 2016 | -6.643M |
| September 30, 2016 | -5.114M |
| June 30, 2016 | -4.463M |
| March 31, 2016 | -3.372M |
| December 31, 2015 | -5.472M |
| September 30, 2015 | -3.382M |
| June 30, 2015 | -4.95M |
| March 31, 2015 | -3.409M |
| December 31, 2014 | -4.823M |
| September 30, 2014 | -4.179M |
| June 30, 2014 | -3.191M |
| March 31, 2014 | -2.337M |
| December 31, 2013 | -4.217M |
| September 30, 2013 | -2.299M |
| June 30, 2013 | -1.881M |
| March 31, 2013 | -0.481M |
| December 31, 2012 | -0.765M |
| September 30, 2012 | -1.022M |
| June 30, 2012 | -1.191M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.821M
Minimum
Jun 2022
-2.998M
Maximum
Dec 2022
-6.110M
Average
-6.271M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
| Compugen Ltd | 9.713M |
| Pluri Inc | -5.293M |
| BioLine Rx Ltd | -13.88M |
| Can Fite Biofarma Ltd | -1.652M |
| BiomX Inc | -5.491M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.578M |
| Total Expenses (Quarterly) | 8.206M |
| EPS Diluted (Quarterly) | -0.13 |
| Enterprise Value | 29.29M |
| Gross Profit Margin (Quarterly) | 31.14% |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | -80.44% |
| Normalized Earnings Yield | -80.44 |